Asia Pacific Radiotherapy Market Report

Asia Pacific Radiotherapy Market Report, By Product (External Beam Radiotherapy, Internal Beam Radiotherapy/Brachytherapy, Systemic Radiotherapy), Application (Prostate, Breast, Lung), Procedure (External (IMRT, IGRT, 3D-CRT), Internal (LDR, HDR)), End User (Hospitals) and Country – Asia Pacific Market Share, Trend Analysis & Forecast , 2019 - 2028

Report Code : 10871 | Publish Date : Upcoming | Industry : Healthcare | Geography : APAC

Radiation therapy involves a machine that directs high-energy beams of radiation at cancer cells. It also plays vital role in shrinkage of tumors. It uses of high-energy radiation from x-rays, gamma rays, neutrons, protons, and other sources. Radiotherapy uses radioactive substances that has ability to travels in the blood to tissues throughout the body. Radiotherapy can be referred as local treatment. The radiation therapy works by damaging the DNA of cancerous cells. Radiation therapy is done to alleviate symptoms in advanced, late-stage cancer.

Market Dynamic- Asia Pacific Radiotherapy Market

The radiotherapy market has been seeing incredible growth from the past few decades. The primary factors for the market growth are increase in geriatric population in Asia Pacific and growing number of awareness campaigns about the benefits of radiotherapy. Besides this, increase in demand for cancer treatment by controlling growth of tumorous cells will fuel market growth. Nevertheless, lack of adequate healthcare infrastructure and difficulty in tumor visualization are the major restraining factor that could hamper the growth of the market.

COVID 19 Impact on Asia Pacific Radiotherapy Market Report

The COVID 19 outbreak had significant impact on the healthcare market. As the rise in COVID 19 cases, for prevention purpose government has announced lockdown in many countries which lead to postponing of radiotherapy procedures which will affect radiotherapy market. Due to closed manufacturing facilities it will disrupted the supply and production chains. The number of emerging patients towards radiotherapy emergency services which is available in almost all centers are reduced. Due to this scenario, COVID 19 negatively impacted the growth of the overall radiotherapy devices market in 2020.


Asia Pacific Radiotherapy Market Segmental Overview

The study analyses Asia Pacific radiotherapy market based on product, application, procedure, end users and country.

Radiotherapy Market By Product

 The various products included in the radiotherapy market is classified into external beam radiotherapy, internal beam radiotherapy/brachytherapy and systemic radiotherapy. The external beam radiotherapy is sub-classified into conventional linear accelerators (LINAC), conventional cobalt-60 teletherapy units, and stereotactic advanced electron and particle therapy systems. The internal beam radiography is sub-classified into seeds, afterloaders, applicators and IORT Systems. The conventional linear accelerators (LINAC) segment dominated the market in 2020 and is expected to maintain its dominance during the forecast period 2021-2027.  

Radiotherapy Market By Application

The radiotherapy market finds its application in the external and internal beam radiotherapy. The external beam radiotherapy is sub-segmented into Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer and Colorectal Cancer. The internal beam radiotherapy/brachytherapy applications market is segmented into prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, and other cancers. The breast cancer segment accounted for the largest share of the external beam radiotherapy market in 2020 because of, highly concentrated radiation dose to the target tumor within less treatment time.

Radiotherapy Market By Procedure

The various procedures used in the radiotherapy market are classified into external and internal beam radiotherapy. The external beam radiotherapy is sub-segmented into Image-guided Radiotherapy, Intensity-modulated Radiotherapy, Stereotactic Therapy, Particle Therapy and 3D Conformal Radiotherapy. The image guided radiotherapy (IGRT) segment dominated the internal beam radiotherapy applications market in 2020. By using IGRT system less exposure to the normal tissue is experienced which will not affect normal functioning of cell. Hence, demand for IGRT in the market has increased.

Radiotherapy Market By End Users

 Depending on the various end users the radiotherapy market is categorized into Hospitals and independent radiotherapy centers. The hospitals segment held the largest share of the market in 2020. The factors responsible for segmental growth are rise in prevalence of cancer globally will causes establishment of new private hospitals for diagnosis and treatment purpose. Besides this, improving healthcare infrastructure will boosts the market growth.

Radiotherapy Market By Country

The countries covered in the Asia-Pacific radiotherapy market report are China, Japan, India and rest of APAC. The China held the largest market share of Asia Pacific radiotherapy market and is likely to dominate the market over the estimated time frame. China is one of the major contributing country in medical field and also it is well developed country. The advancement in radiotherapy is major factor for the market growth in the region.

Asia Pacific Radiotherapy Market Key Players

The major key players of market includes Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), BD (US), Eckert & Ziegler (Germany), Hitachi Ltd. (Japan), ICAD, Inc. (US), IntraOp Medical, Inc. (US), IsoRay Medical, Inc. (US), Mevion Medical Systems, Inc. (US), Panacea Medical Technologies Pvt. Ltd. (India), P-cure Ltd. (Israel),ViewRay, Inc. (US) and ZEISS Group (Germany)

Recent Developments:

November 2020: Elekta AB (Sweden) received CE mark for the Elekta Harmony linear accelerator, clearing the technology for commercial sales in Europe.

April 2020: Elekta AB (Sweden) launched Geneva, the first universal gynecological applicator for brachytherapy. Geneva applicator is CE-marked and has received US FDA 510(k) clearance. It is used for cervical cancer up to stage IIB.

June 2020: Accuray Incorporated (US) launched the CyberKnife S7 System, an innovative device combining speed, advanced precision, and real-time AI-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments.

The study analyses Asia Pacific radiotherapy market product, application, procedure, end users and country. Radiotherapy plays key role in treating cancer by radiating the tumor cells and destructing its growth and division procedure. The primary growth factors behind the market growth are technological advancements and expansion of the target patient population. The application areas in radiotherapy market are prostate cancer, breast cancer, lung cancer, head and neck Cancer and colorectal cancer. Besides this, increasing applications of radiotherapy and increasing R&D funding for pharma and biotech companies will boosts the market growth. Improving healthcare infrastructure in many regions will drive radiotherapy market growth in upcoming years. The rise in adoption of radiotherapy products in all over the population is expected to impede market growth over the forecast period 2021-2027.  Country wise study comprises countries like China, India, Japan and rest of Asia Pacific. The China held the largest market share of Asia Pacific radiotherapy market and is likely to dominate the market over the estimated time frame.

Why to buy this report:

  • The report offers changing market dynamics in the Asia Pacific radiotherapy market industry, presenting historical, current and projected market size in terms of value (USD Million)
  • The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of the Asia Pacific radiotherapy market
  • It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments and a neutral perspective of the Asia Pacific radiotherapy market performance